Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
20,660 total articles
GlobalFoundries and RAAAM Memory Technologies have successfully taped out a Gain-Cell RAM (GCRAM) test chip on GlobalFoundries' FDX FD-SOI platform. This collaboration aims to deliver higher-density, lower-power on-chip memory solutions optimized for edge AI, automotive, and IoT markets. The new memory technology offers significant area and power s…
Maris-Tech Ltd., a Nasdaq-listed Israeli company specializing in video and AI-based edge computing technology for defense and aerospace sectors, announced a 194% increase in revenue to approximately $2.1 million for the first half of 2026. Despite this strong revenue growth, the company reported a net loss of $2.8 million compared to net income of …
Fluent, Inc., a commerce media solutions provider, announced its CEO and CFO will participate in the 19th Annual Barrington Research Virtual Fall Investment Conference, engaging in one-on-one meetings to discuss company performance and outlook.
ProQR Therapeutics, a clinical-stage company specializing in RNA therapies, announced management's participation in Wells Fargo and Cantor Global Healthcare investor conferences in September 2026. The company will discuss its pioneering Axiomer™ RNA editing technology, which aims to develop new medicines by correcting RNA mutations. Webcasts will b…
Insight Molecular Diagnostics Inc. announced its participation in the upcoming Lake Street Capital Markets 10th Annual Best Ideas Growth Conference scheduled for September 10, 2026, where its CEO and CFO will engage in one-on-one investor meetings in New York City.
CG Oncology, Inc., a late-stage clinical biopharmaceutical company focused on bladder cancer immunotherapies, announced the participation of its CEO, Arthur Kuan, in the Cantor Fitzgerald and Morgan Stanley Global Healthcare Conferences in September 2026. The company will webcast the presentations live and make replays available to investors.
vTv Therapeutics Inc., a late-stage biopharmaceutical company developing an oral investigational therapy for type 1 diabetes, will participate in two major investor conferences in September. The company’s leading drug candidate, cadisegliatin, a novel oral glucokinase activator with Breakthrough Therapy designation, is currently being evaluated in …
Milestone Pharmaceuticals Inc., a biopharmaceutical company specializing in cardiovascular medicines, announced that its management will present at several forthcoming investor conferences including Wells Fargo, Cantor Global Healthcare, and H.C. Wainwright. The company is known for its lead FDA-approved product CARDAMYST, a nasal spray treating pa…
The U.S. Court of Appeals for the Second Circuit officially vacated a preliminary injunction that had restricted Genius Group Limited from issuing shares, raising capital, and purchasing Bitcoin. This marks the end of an 18-month legal battle with LZG International. The lifting of the injunction allows Genius Group to fully proceed with its board-a…
Aligos Therapeutics, a clinical-stage biotech company focused on liver and viral diseases, announced its management will present at the Cantor Global Healthcare Conference on September 9, 2026. The presentation will review the company's scientific approach and development of therapies, particularly for chronic hepatitis B. The company also highligh…
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company specializing in nitric oxide therapies, announced its management will participate in the 2026 Cantor Global Healthcare Conference. The company will hold a fireside chat and offer a webcast to discuss its latest developments, including its FDA-approved LungFit PH syste…
UroGen Pharma Ltd., a biotech company focused on urothelial and specialty cancers, announced it will participate in key healthcare investor conferences in September 2026, including Wells Fargo, Cantor Global, and H.C. Wainwright events. Presentations will be webcast and available for replay on the company's website.
Design Therapeutics, a clinical-stage biotech company developing GeneTAC® gene targeted chimera small molecule therapies for degenerative genetic diseases, announced management will participate in a fireside chat at the 2026 Cantor Fitzgerald Global Healthcare Conference. The webcast will highlight the company's pipeline, including programs for Fri…
DDC Enterprises Ltd. reported significant progress in the first half of 2026, showing a 29% revenue increase in its Asian food platform, positive adjusted EBITDA, and a large expansion of its Bitcoin treasury to 2,899 BTC. The company improved its working capital position substantially and launched a share repurchase program, while continuing to de…
Madrigal Pharmaceuticals announced its participation in the 2026 Cantor Global Healthcare Conference where it will present its progress and pipeline advancements. The company specializes in treatments for metabolic dysfunction-associated steatohepatitis (MASH), highlighting its drug Rezdiffra, the first FDA and European Commission approved medicati…
Diginex Limited announced the departure of CEO Lubomila Jordanova and appointed interim CEO Archana Kotecha amid efforts to integrate recent acquisitions. The company also filed a listing application with Nasdaq seeking approval for a change of control related to the planned acquisition of Resulticks Global Companies Pte. Limited.
DDC Enterprise Limited announced a 29% year-over-year revenue increase to $20.2 million and positive non-GAAP Adjusted EBITDA of $1.2 million for the first half of 2026. The company improved working capital from negative $12.2 million to positive $39.4 million, grew total shareholders' equity substantially, and increased Bitcoin holdings by 145%. D…
Teamshares Inc., a NASDAQ-listed tech-enabled acquirer of small and medium-sized enterprises (SMEs), announced that its CEO Michael Brown and CFO Brian Gaebe will present at the Northcoast Research Virtual Small Cap Management Forum and the Sidoti Virtual Small Cap Conference in September 2026. Presentations and investor meetings will provide insig…
GrowGeneration Corp., a leading US supplier of specialty products for controlled environment agriculture and commercial cultivation, announced that CEO Darren Lampert will present virtually at the upcoming H.C. Wainwright 28th Annual Global Investment Conference. The presentation will be available on demand starting September 11, and the company wi…
Geron Corporation, a hematology-focused biopharmaceutical company, announced the participation of its management team in upcoming 2026 healthcare investment conferences. The company will discuss their drug RYTELO® (imetelstat), currently approved for lower-risk myelodysplastic syndromes, and ongoing pivotal Phase 3 trials in myelofibrosis and other…
NewAmsterdam Pharma, a biopharmaceutical company specializing in oral non-statin drugs for cardiovascular risk patients with elevated LDL cholesterol, will present at two major healthcare investor conferences in September 2026. The company aims to highlight progress on its late-stage clinical candidate obicetrapib, a CETP inhibitor, which is being …
Nasdaq has completed its acquisition of Dasseti, an AI-powered platform specializing in due diligence and monitoring for investment consultants and institutional investors. Integrating Dasseti's technology into Nasdaq eVestment will extend the platform's coverage and improve efficiency in manager research, due diligence, and monitoring, especially …
InterDigital, Inc., a US-based technology development company, announced that it won a third injunction against Disney by the Unified Patent Court in Europe regarding infringements on their video technology patents. The latest injunction covers Germany and the Netherlands, with previous injunctions also secured in multiple jurisdictions globally. T…
Ascentage Pharma, a global biopharmaceutical company listed on NASDAQ and HKEX, announced its management's participation in four upcoming investor conferences in New York in September 2026. The company highlighted its novel cancer therapies pipeline, including approved products Olverembatinib and Lisaftoclax, and ongoing global registrational Phase…
Annexon, Inc. announced that its CEO, Douglas Love, will participate in several investor conferences in September 2026, including events hosted by Wells Fargo, Cantor Global Healthcare, and H.C. Wainwright. The company focuses on developing targeted immunotherapies for neuroinflammatory diseases by inhibiting the classical complement pathway. Live …
